🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lee Ainslie’s ABBV Holdings & Trades

First Buy
Q2 2014
Duration Held
22 Quarters
Largest Add
Q2 2014
+3.24 M Shares
Current Position
1,018 Shares
$266,299 Value

Lee Ainslie's ABBV Position Overview

Lee Ainslie (via Maverick Capital LTD) currently holds 1,018 shares of AbbVie Inc. (ABBV) worth $266,299, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 22 quarters.

Based on 13F filings, Lee Ainslie has maintained a strategic position in ABBV, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2014, adding 1.49 M shares. Largest reduction occurred in Q4 2014, reducing 4.72 M shares.

Analysis based on 13F filings available since 2013 Q2

Lee Ainslie's AbbVie (ABBV) Holding Value Over Time

Track share changes against reported price movement

Quarterly AbbVie (ABBV) Trades by Lee Ainslie

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +1,018 New Buy 1,018 $261.59
Q4 2023 -6,073 Sold Out 0 $0.00
Q3 2023 +6,073 New Buy 6,073 $149.06
Q4 2021 -11,681 Sold Out 0 $0.00
Q3 2021 -2,598 Reduce 18.19% 11,681 $107.87
Q2 2021 +14,279 New Buy 14,279 $112.61
Q1 2021 -6,210 Sold Out 0 $0.00
Q4 2020 +4,188 Add 207.12% 6,210 $107.09
Q3 2020 +2,022 New Buy 2,022 $87.54
Q3 2017 -57,400 Sold Out 0 $0.00
Q2 2017 +13,000 Add 29.28% 57,400 $72.51
Q1 2017 -6,520 Reduce 12.80% 44,400 $65.16
Q4 2016 +1,320 Add 2.66% 50,920 $62.63
Q3 2016 -940 Reduce 1.86% 49,600 $63.06
Q2 2016 +7,370 Add 17.07% 50,540 $61.91
Q1 2016 +43,170 New Buy 43,170 $57.12
Q3 2015 -3,950 Sold Out 0 $0.00
Q2 2015 -370 Reduce 8.56% 3,950 $67.09
Q1 2015 +4,320 New Buy 4,320 $58.56
Q4 2014 -4.72 M Sold Out 0 $0.00
Q3 2014 +1.49 M Add 46.01% 4.72 M $57.76
Q2 2014 +3.24 M New Buy 3.24 M $56.44

Lee Ainslie's AbbVie Investment FAQs

Lee Ainslie first purchased AbbVie Inc. (ABBV) in Q2 2014, acquiring 3,235,133 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Lee Ainslie has held AbbVie Inc. (ABBV) for 22 quarters since Q2 2014.

Lee Ainslie's largest addition to AbbVie Inc. (ABBV) was in Q2 2014, adding 3,235,133 shares worth $182.59 M.

According to the latest 13F filing for Q3 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 1,018 shares of AbbVie Inc. (ABBV), valued at approximately $266,299.

As of the Q3 2026 filing, AbbVie Inc. (ABBV) represents approximately 0.00% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.

Lee Ainslie's peak holding in AbbVie Inc. (ABBV) was 4,723,578 shares, as reported at the end of Q3 2014.